These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
186 related articles for article (PubMed ID: 16274294)
21. Antisense mapping the MOR-1 opioid receptor: evidence for alternative splicing and a novel morphine-6 beta-glucuronide receptor. Rossi GC; Pan YX; Brown GP; Pasternak GW FEBS Lett; 1995 Aug; 369(2-3):192-6. PubMed ID: 7649256 [TBL] [Abstract][Full Text] [Related]
22. Tetrapeptide Endomorphin Analogs Require Both Full Length and Truncated Splice Variants of the Mu Opioid Receptor Gene Oprm1 for Analgesia. Marrone GF; Lu Z; Rossi G; Narayan A; Hunkele A; Marx S; Xu J; Pintar J; Majumdar S; Pan YX; Pasternak GW ACS Chem Neurosci; 2016 Dec; 7(12):1717-1727. PubMed ID: 27648914 [TBL] [Abstract][Full Text] [Related]
23. Mediation of opioid analgesia by a truncated 6-transmembrane GPCR. Lu Z; Xu J; Rossi GC; Majumdar S; Pasternak GW; Pan YX J Clin Invest; 2015 Jul; 125(7):2626-30. PubMed ID: 26011641 [TBL] [Abstract][Full Text] [Related]
24. Isolating and characterizing three alternatively spliced mu opioid receptor variants: mMOR-1A, mMOR-1O, and mMOR-1P. Xu J; Xu M; Bolan E; Gilbert AK; Pasternak GW; Pan YX Synapse; 2014 Apr; 68(4):144-52. PubMed ID: 24375714 [TBL] [Abstract][Full Text] [Related]
25. Involvement of exon 11-associated variants of the mu opioid receptor MOR-1 in heroin, but not morphine, actions. Pan YX; Xu J; Xu M; Rossi GC; Matulonis JE; Pasternak GW Proc Natl Acad Sci U S A; 2009 Mar; 106(12):4917-22. PubMed ID: 19273844 [TBL] [Abstract][Full Text] [Related]
26. Molecular insights into mu opioid pharmacology: From the clinic to the bench. Pasternak GW Clin J Pain; 2010 Jan; 26 Suppl 10(Suppl 10):S3-9. PubMed ID: 20026962 [TBL] [Abstract][Full Text] [Related]
27. Endogenous Opioid Peptides and Alternatively Spliced Mu Opioid Receptor Seven Transmembrane Carboxyl-Terminal Variants. Abrimian A; Kraft T; Pan YX Int J Mol Sci; 2021 Apr; 22(7):. PubMed ID: 33917474 [TBL] [Abstract][Full Text] [Related]
28. Identification and functional significance of polymorphisms in the mu-opioid receptor gene (Oprm) promoter of C57BL/6 and DBA/2 mice. Doyle GA; Sheng XR; Schwebel CL; Ferraro TN; Berrettini WH; Buono RJ Neurosci Res; 2006 Jul; 55(3):244-54. PubMed ID: 16644048 [TBL] [Abstract][Full Text] [Related]
29. Promoter region and alternatively spliced exons of the rat mu-opioid receptor gene. Mayer P; Schulzeck S; Kraus J; Zimprich A; Höllt V J Neurochem; 1996 Jun; 66(6):2272-8. PubMed ID: 8632148 [TBL] [Abstract][Full Text] [Related]
30. Morphine regulates expression of μ-opioid receptor MOR-1A, an intron-retention carboxyl terminal splice variant of the μ-opioid receptor (OPRM1) gene via miR-103/miR-107. Lu Z; Xu J; Xu M; Pasternak GW; Pan YX Mol Pharmacol; 2014 Feb; 85(2):368-80. PubMed ID: 24302561 [TBL] [Abstract][Full Text] [Related]
31. Isolation and expression of a novel alternatively spliced mu opioid receptor isoform, MOR-1F. Pan YX; Xu J; Bolan E; Chang A; Mahurter L; Rossi G; Pasternak GW FEBS Lett; 2000 Jan; 466(2-3):337-40. PubMed ID: 10682855 [TBL] [Abstract][Full Text] [Related]
32. The pharmacology of mu analgesics: from patients to genes. Pasternak GW Neuroscientist; 2001 Jun; 7(3):220-31. PubMed ID: 11499401 [TBL] [Abstract][Full Text] [Related]
33. Stabilization of the μ-opioid receptor by truncated single transmembrane splice variants through a chaperone-like action. Xu J; Xu M; Brown T; Rossi GC; Hurd YL; Inturrisi CE; Pasternak GW; Pan YX J Biol Chem; 2013 Jul; 288(29):21211-21227. PubMed ID: 23760268 [TBL] [Abstract][Full Text] [Related]
34. Dysregulated expression of the alternatively spliced variant mRNAs of the mu opioid receptor gene, OPRM1, in the medial prefrontal cortex of male human heroin abusers and heroin self-administering male rats. Brown TG; Xu J; Hurd YL; Pan YX J Neurosci Res; 2022 Jan; 100(1):35-47. PubMed ID: 32506472 [TBL] [Abstract][Full Text] [Related]
35. Exploring μ-Opioid Receptor Splice Variants as a Specific Molecular Target for New Analgesics. Mizoguchi H; Fujii H Curr Top Med Chem; 2020; 20(31):2866-2877. PubMed ID: 32962616 [TBL] [Abstract][Full Text] [Related]
36. Alternatively spliced mu opioid receptor C termini impact the diverse actions of morphine. Xu J; Lu Z; Narayan A; Le Rouzic VP; Xu M; Hunkele A; Brown TG; Hoefer WF; Rossi GC; Rice RC; Martínez-Rivera A; Rajadhyaksha AM; Cartegni L; Bassoni DL; Pasternak GW; Pan YX J Clin Invest; 2017 Apr; 127(4):1561-1573. PubMed ID: 28319053 [TBL] [Abstract][Full Text] [Related]
37. A Truncated Six Transmembrane Splice Variant MOR-1G Enhances Expression of the Full-Length Seven Transmembrane Zhang T; Xu J; Pan YX Mol Pharmacol; 2020 Oct; 98(4):518-527. PubMed ID: 32723770 [TBL] [Abstract][Full Text] [Related]
38. Modulation of OPRM1 Alternative Splicing by Morphine and HIV-1 Nef. Donadoni M; Huang W; Yarandi SS; Burdo TH; Chang SL; Sariyer IK J Neuroimmune Pharmacol; 2022 Jun; 17(1-2):277-288. PubMed ID: 34420144 [TBL] [Abstract][Full Text] [Related]
39. Truncated mu opioid GPCR variant involvement in opioid-dependent and opioid-independent pain modulatory systems within the CNS. Marrone GF; Grinnell SG; Lu Z; Rossi GC; Le Rouzic V; Xu J; Majumdar S; Pan YX; Pasternak GW Proc Natl Acad Sci U S A; 2016 Mar; 113(13):3663-8. PubMed ID: 26976581 [TBL] [Abstract][Full Text] [Related]
40. Immunohistochemical study of the expression of exon11-containing mu opioid receptor variants in mouse brain. Abbadie C; Pan YX; Pasternak GW Neuroscience; 2004; 127(2):419-30. PubMed ID: 15262332 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]